SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mathieu Capovilla, Effets secondaires carcinogènes et résistances aux thérapies ciblées anti-BRAF, Annales de Pathologie, 2013, 33, 6, 375

    CrossRef

  2. 2
    Marcus C. Ravnan, Mazen S. Matalka, Vemurafenib in Patients With BRAF V600E Mutation–Positive Advanced Melanoma, Clinical Therapeutics, 2012, 34, 7, 1474

    CrossRef

  3. 3
    Yongmei Feng, Elisa Barile, Surya K. De, John L. Stebbins, Apple Cortez, Pedro Aza-Blanc, Jessie Villanueva, Meenhard Heryln, Stan Krajewski, Maurizio Pellecchia, Ze’ev A. Ronai, Gary G. Chiang, Effective inhibition of melanoma by BI-69A11 is mediated by dual targeting of the AKT and NF-κB pathways, Pigment Cell & Melanoma Research, 2011, 24, 4